Cargando…
Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs
Glutamate is one of the most abundant amino acids in the blood. Besides its role as a neurotransmitter in the brain, it is a key substrate in several metabolic pathways and a primary messenger that acts through its receptors outside the central nervous system (CNS). The two main types of glutamate r...
Autores principales: | García-Gaytán, Ana Cristina, Hernández-Abrego, Andy, Díaz-Muñoz, Mauricio, Méndez, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705578/ https://www.ncbi.nlm.nih.gov/pubmed/36457557 http://dx.doi.org/10.3389/fendo.2022.1029210 |
Ejemplares similares
-
Circadian and Metabolic Perspectives in the Role Played by NADPH in Cancer
por: Méndez, Isabel, et al.
Publicado: (2018) -
Mechanistic Effects of Calcitriol in Cancer Biology
por: Díaz, Lorenza, et al.
Publicado: (2015) -
Overlapping Neural Endophenotypes in Addiction and Obesity
por: Michaud, Andréanne, et al.
Publicado: (2017) -
Fibroblast Growth Factor 19 Increases the Excitability of Pre-Motor Glutamatergic Dorsal Vagal Complex Neurons From Hyperglycemic Mice
por: Wean, Jordan B., et al.
Publicado: (2021) -
Maternal Diabetes and Fetal Programming Toward Neurological Diseases: Beyond Neural Tube Defects
por: Márquez-Valadez, Berenice, et al.
Publicado: (2018)